Navigation Links
United States Patent Office Grants CryoCor's Request for Patent Interference
Date:2/13/2008

r intellectual property position in the field of cryoablation."

About CryoCor

CryoCor is a medical technology company that has developed and manufactures a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The Company's product, the CryoCor Cardiac Cryoablation System, or the Cryoablation System, is designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The Cryoablation System has been approved in Europe for the treatment of atrial fibrillation, and atrial flutter, the two most common and difficult to treat arrhythmias, since 2002. In the United States, CryoCor is conducting a pivotal trial to evaluate the safety and efficacy of the Cryoablation System for the treatment of atrial fibrillation and the Cryoablation System has been approved for the treatment of right atrial flutter. For more information please visit the Company's website at http://www.cryocor.com.

Forward Looking Statements

The statements in this press release that are not descriptions of historical facts are forward-looking statements that are subject to risks and uncertainties. These include statements related to the merits of CryoCor's positions in its interference proceedings with CryoCath and the possible outcome of those proceedings, the likelihood of a second interference being declared and the value of pre-cooling technology in a cryoablation system, and specifically, CryoCath's cryoablation system, all of which are prospective. Such statements are only predictions and reflect CryoCor's expectations and assumptions as of the date of this press release based on currently available operating, financial, and competitive information. The actual events or results may differ materially from those projected in such forward-looking statements due to a number of factors, inc
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. United Therapeutics to Announce Fourth Quarter and Annual 2007 Financial Results Before Market Open on Tuesday, February 19, 2008
2. Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements
3. Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor
4. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
5. Neptune Technologies receives GRAS notification in the United States
6. Essilor: New Acquisitions in the United States and Brazil
7. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
8. Medical Services Begins Working With United States Companies for Distribution of Its Products
9. United Therapeutics Reports Third Quarter 2007 Financial Results
10. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
11. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...K, Dec. 1 Reportlinker.com announc...in its catalogue: ,, Chromium - Global Market...494/Chromium---Global-Market-Trends.html ,, Wo...d by stainless steel, while growth in aerospace an... for growth of chromium metal. Environmental const...
(Date:12/1/2009)...ajority Leader Richard Gephardt Brings Together A-...Communities for "Best and Brightest Forum on Medi... Several of New Jersey,s...earch, medicine and technology gathered today at t...e of medical innovation in New Jersey, and through...
(Date:12/1/2009)... Enterprise level storage is now available to smal...reaking the bank. , (PRWE...drive.com ), a medical imaging software company, ...oud storage service. The PacsDrive service enables...ecurely archive medical imaging in compliance with...
(Date:12/1/2009)...INGTON BEACH, California and AMSTERDAM, December 1...lar cancer diagnostics, announced today that,Palme...r, has established,coding guidelines for the compa...cleared breast cancer recurrence test, which has b...tients across the United States can now submit cla...
Breaking Biology Technology:Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2
...tion,(OTC Bulletin Board: LQWC) is pleased to anno...nXT, their Immune System enhancement supplement, h...rket as of March 2008.,ImmunXT has been proclaimed...supplement ever discovered". ImmunXT (US Patent #7...xtracted from Spirulina. Clinically,tested at The ...
...rporated (OTC Bulletin Board: GNTA) announced toda...stry Regulatory Authority (FINRA, formerly,the NAS...on to quote the,Company,s stock on the Over-the-Co...pany expects that trading and quotations for the C... 7, 2008. The Company,s trading,symbol will remain...
...,Incorporated (Nasdaq: KOSN ) announced today tha...mmunications, will present at the Leerink Swann,So...e Grand Hyatt Hotel on,Friday, May 9, 2008 at 11:1... be accessed through http://www.wsw.com/webcast/l...ess a live webcast of the presentation,by visiting...
Other Biology Technology:LifeQuest World Launches Immune System Boosting Supplement to the North American Market 2Genta Announces Transfer of its Common Stock to the OTC Bulletin Board 2Genta Announces Transfer of its Common Stock to the OTC Bulletin Board 3Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference 2
(Date:12/1/2009)...e scientists, one from the United States, the othe... the leader of his wolf pack, on remote Ellesmere ...goal to finally find out what these "North Pole w...of the harshest areas of the world., "We first e...avid Mech, a renowned U.S. Geological Survey (USGS...
(Date:12/1/2009)..., NEW YORK, Dec. 1 iQor, a global ...vices, was included in the 2009 InfoWorld 100 Aw...enabled ERP system, TeQ21. This was the first subm...nized among this prestigious list of companies," s...1 is completely transforming the way we do busines...
(Date:12/1/2009)...ND, Wash. -- Time-lapsed video of individual breas...n the life of a cell: a protein that cycles betwee...give researchers a more complete view of the inter..., events that go awry in cancer and are targets of...ps cells respond to growth factors, travels back a...
Breaking Biology News(10 mins):North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research 51012 1Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research 51012 2DOE funds Clemson University clean energy research 51009 1DOE funds Clemson University clean energy research 51009 2US Mexico border wall could threaten wildlife species 9151 1US Mexico border wall could threaten wildlife species 9151 2US Mexico border wall could threaten wildlife species 9151 3US Mexico border wall could threaten wildlife species 9151 4
...etric USB Portable Drive to ship This Quarter, JE... Board: BMRX) a leading provider of biometrically ...is scheduled to commence shipping it,s,second cons...age device,next week., smartSTIK(TM), is a finger... ability to securely download and carry personal d...
...lest plants on the planet could help scientists cr...he moss Physcomitrella patens is a primitive plant...on land around 450 million years ago. Just one cel...and cold, heat and drought without roots or comple...dehydration and then regrow when watered could be ...
...007) The journal Science has published a paper tod...f the effects rising ocean temperatures are having...oral Reefs under Rapid Climate Change and Ocean Ac...tists from seven different countries, reveals that...reases in global temperatures and atmospheric CO2 ...
Other Biology News:bioMETRX Announces Availability of New smartTOUCH(TM) Product 2bioMETRX Announces Availability of New smartTOUCH(TM) Product 3Moss is a super model for feeding the hungry 2Immediate action needed to save corals from climate change 2Immediate action needed to save corals from climate change 3
50X Denhardt's Solution from Invitrogen
...fection technology, SilenceMag is the most efficie...and easy to use, SilenceMag is serum compatible an...ery, SilenceMag allows studying gene silencing at ...ves reliable high gene silencing efficiencies in n...
...NEN Radiolabeled Ligands\n\nReceptor-related resea...ility of new radiolabeled ligands selected to keep...ide range of products and services for receptor re...e-of-the-art radioligands. If you do not find exac...
Rabbit Anti-Wilm's Tumor Protein Polyclonal Antibody, Unconjugated from Calbiochem
Biology Products: